Short-term effects of population-based screening for prostate cancer on health-related quality of life.

BACKGROUND Population-based screening for prostate cancer is currently being evaluated in randomized clinical trials in the United States and in Europe. Side effects arising from the process of screening and from the earlier treatment of screen-detected prostate cancer may be important factors in the evaluation. To examine health-related quality of life (or health status) among men screened for prostate cancer, we conducted a longitudinal study of 626 attenders to the Rotterdam (The Netherlands) prostate cancer screening program and of 500 nonparticipants. METHODS Attenders of the screening program and nonparticipants completed self-assessment questionnaires (SF-36 [i.e., Medical Outcomes Study 36-Item Short-Form Health Survey] and EQ-5D [i.e., EuroQol measure for health-related quality of life] health surveys) to measure generic health status, as well as an additional questionnaire for anxiety and items relating to prostate cancer screening. RESULTS Physical discomfort during digital rectal examination and during transrectal ultrasound was reported by 181 (37%) of 491 men and by 139 (29%) of 487 men, respectively; discomfort during prostate biopsy was reported by 64 (55%) of 116 men. Mean scores for health status and anxiety indicated that the participants did not experience relevant changes in physical, psychological, and social functioning during the screening procedure. However, high levels of anxiety were observed throughout the screening process among men with a high predisposition to anxiety. Similar scores for anxiety predisposition were observed among attenders and nonparticipants. CONCLUSIONS At the group level, we did not find evidence that prostate cancer screening induced important short-term health-status effects, despite the short-lasting side effects related to the biopsy procedure. However, subgroups may experience high levels of anxiety. The implication is that unfavorable health-status effects of prostate cancer screening occur mainly in the treatment phase.

[1]  W H Rogers,et al.  Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. , 1995, Medical care.

[2]  L. Denis,et al.  The European randomized study of screening for prostate cancer , 1997, Cancer.

[3]  H. D. de Koning,et al.  European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam Pilot studies , 1995, Cancer.

[4]  F. Schröder,et al.  Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. , 1997, Urology.

[5]  S. Sutton,et al.  Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. , 1995, Journal of epidemiology and community health.

[6]  T. Tammela,et al.  Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland. , 1996, British Journal of Cancer.

[7]  H. D. de Koning,et al.  Advanced breast cancer and its prevention by screening. , 1992, British Journal of Cancer.

[8]  P. Prorok,et al.  Prospective Evaluation Plan for Randomised Trials of Prostate Cancer Screening , 1996, Journal of medical screening.

[9]  Harry J. de Koning,et al.  The impact of a breast cancer screening programme on quality‐adjusted life‐years , 1991, International journal of cancer.

[10]  A. Farmer,et al.  Working together to reduce poverty's damage , 1997, BMJ.

[11]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[12]  J. Cockburn,et al.  Psychological Consequences of Screening Mammography , 1994, Journal of medical screening.

[13]  B. Trock,et al.  Psychological side effects of breast cancer screening. , 1991, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[14]  C. Spielberger,et al.  STAI manual for the State-trait anxiety inventory ("self-evaluation questionnaire") , 1970 .

[15]  P C Prorok,et al.  A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers , 2010, Cancer.

[16]  R. Brooks.  EuroQol: the current state of play. , 1996, Health policy.

[17]  B. G. Blijenberg,et al.  European randomized study of screening for prostate cancer—The Rotterdam pilot studies , 1996, International journal of cancer.